| P/E (FY) | — | Sales (TTM) | $870.5M |
| Earnings (TTM) | -$608.8M | ROE | −41.88% |
| Net Margin | −122.06% | ROIC | −25.02% |
| Debt / Equity | 0.43 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 19.28% |
Neogen Corporation develops, manufactures, and markets products and services for food and animal safety in the United States and internationally, operating through Food Safety and Animal Safety segments. The Food Safety segment provides diagnostic test kits for foodborne pathogens, toxins, allergens, drug and pesticide residues, and sanitation, along with culture media, sample collection products, analysis software, and laboratory services.
| Market Cap | $2.00B | Trading Days | 5292 |
| 52W High | 11.43 |
| 52W Low | 4.56 |
| % Off High | −19.60% |
| YTD | 31.47% | 1Y | 69.56% |
| 3Y | −60.20% | 5Y | −78.92% |
| 10Y | −55.58% | Since incept. (ann.) | 8.65% |
Food Safety 71% · Animal Safety 29%
| Ann. Volatility (1Y) | 57.77% | Ann. Volatility (3Y) | 55.46% |
| Sharpe (1Y) | 1.20 | Sharpe (3Y) | −0.26 |
| Max Drawdown (1Y) | −27.71% | Max Drawdown (3Y) | −81.59% |
| Beta (3Y, vs SPY) | 1.91 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | $1.52B | — |
| CLDX | Celldex Therapeutics, Inc. | $2.79B | — |
| QDEL | QuidelOrtho Corp | $1.14B | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $634.4M | — |
| LNTH | Lantheus Holdings, Inc. | $6.68B | 30.1 |
| MYGN | MYRIAD GENETICS INC | $502.5M | — |
| TKNO | Alpha Teknova, Inc. | $260.0M | — |
| IMDX | Insight Molecular Diagnostics Inc. | $148.9M | — |
| ICCC | IMMUCELL CORP /DE/ | $101.7M | — |
| IDXX | IDEXX LABORATORIES INC /DE | $44.93B | 43.5 |
| QCLS | Q/C TECHNOLOGIES, INC. | $25.3M |
| — |
| BMRA | BIOMERICA INC | $4.9M | — |